Tech Company Financing Transactions

Accu-Break Pharmaceuticals Funding Round

On 5/20/2013, Accu-Break Pharmaceuticals raised $1 million in funding from private investors.

Transaction Overview

Announced On
5/20/2013
Transaction Type
Debt
Venture Equity
Amount
$1,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6100 Hollywood Blvd. 307
Hollywood, FL 33024
USA
Email Address
Overview
Accu-Break develops pharmaceutical tablet technologies to create tablets that can be easily divided by hand into exact smaller doses.
Profile
Accu-Break Pharmaceuticals LinkedIn Company Profile
Social Media
Accu-Break Pharmaceuticals Company Twitter Account
Company News
Accu-Break Pharmaceuticals News
Facebook
Accu-Break Pharmaceuticals on Facebook
YouTube
Accu-Break Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chairman
Elliot Hahn
  Elliot Hahn LinkedIn Profile  Elliot Hahn Twitter Account  Elliot Hahn News  Elliot Hahn on Facebook
Co-Founder
David Lucking
  David Lucking LinkedIn Profile  David Lucking Twitter Account  David Lucking News  David Lucking on Facebook
President
Robert Goldfarb
  Robert Goldfarb LinkedIn Profile  Robert Goldfarb Twitter Account  Robert Goldfarb News  Robert Goldfarb on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/19/2013: GetMyRx venture capital transaction
Next: 5/20/2013: Alteryx venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on tech company VC transactions. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary